Connect your AI

Evolent Health, Inc. EVH Treasury Stock

Treasury Stock at other companies

CVS HealthCVS

$36.71B-0.1%

The Oncology Institute, Inc.TOI

$1.02M0.0%

PhreesiaPHR

$46.62M+2.4%

CencoraCOR

$10.44B+1.0%

ExlService HoldingsEXLS

$1.26B+56.6%

CorvelCRVL

$887.72M+6.8%

Other financials

Income statement

Revenue$496.2M+2.6%

Gross profit$83.8M-18.2%

Operating income-$10.6M-553%

Net income-$26.6M+58.8%

EPS (diluted)-$0.24+61.9%

Balance sheet

Cash & equivalents$142.0M-42.4%

Total debt$985.4M+13.3%

Total equity$396.4M-57.6%

Total assets$1.9B-29.2%

Cash flow

Operating cash flow-$984.0K-122%

Valuation

Market cap$565.78M-47.9%

Enterprise value$1.41B-17.6%

P/S0.3×-0.2×

Profitability

Gross margin20.2%+4.9pp

Operating margin-22.2%-23.5pp

Net margin-26.3%-33.2pp

FCF margin-9.7%—

Returns & leverage

Return on equity-74.6%-90.1pp

Debt / equity2.5×+1.6×

Current ratio1.3×+0.3×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Evolent Health, Inc.'s treasury stock?: Evolent Health, Inc. (EVH) reported treasury stock of $61.43M in Q1 2026.
How has Evolent Health, Inc.'s treasury stock changed year-over-year?: Evolent Health, Inc.'s treasury stock increased by 190.8% year-over-year, from $21.12M to $61.43M.
What is the long-term trend for Evolent Health, Inc.'s treasury stock?: Over 5 years (2020 to 2025), Evolent Health, Inc.'s treasury stock has grown at a 23.8% compound annual growth rate (CAGR), from $21.12M to $61.43M.
What does treasury stock mean?: Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.